Print page |
Email page
| 
Download PDF
« Previous Release | Next Release »
SAN DIEGO, May 5, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's President and CEO Theodore Schroeder will present a corporate overview at the following investment conferences:
-- Bank of America Merrill Lynch 2009 Healthcare Conference at the Palace
Hotel in New York City on Tuesday, May 12, 2009 at 2:40pm Eastern Time
(11:40am Pacific Time)
-- Deutsche Bank's 34th Annual Health Care Conference at the
InterContinental Hotel in Boston on Tuesday, May 19, 2009 at 1:55pm
Eastern Time (10:55am Pacific Time)
Each presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com. To access the presentations, click on the Investor Relations tab the link entitled "Events and Presentations" on the left side of the screen. A replay of each webcast will available approximately one hour after the live webcast concludes and will remain available for 30 days.
About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. The company is currently developing Acetavance(TM) (intravenous acetaminophen), its investigational product candidate for the treatment of acute pain and fever. For more information about Cadence's pipeline, visit www.cadencepharm.com.
Cadence(TM) and Acetavance(TM) are trademarks of Cadence Pharmaceuticals, Inc.
Contacts: William R. LaRue
SVP, CFO
Cadence Pharmaceuticals, Inc.
858-436-1400
SOURCE Cadence Pharmaceuticals, Inc.
http://www.cadencepharm.com
Copyright (C) 2009 PR Newswire. All rights reserved